BUZZ-DaVita rises on upbeat annual profit forecast

-0.30%

DaVita Inc.

DVA

149.31

-0.30%

** Dialysis firm DaVita's DVA.N shares rise 10.6% to $121.05 premarket after co forecasts annual profit above estimates

** Co expects 2026 adj. EPS to be between $13.60 and $15 vs analysts' average estimate of $12.65 - LSEG data

** DVA attributes upbeat estimate to steady demand for its kidney dialysis services

** Barclays raises PT to $158 from $143, an upside of 42% to DVA's last close of $111.19

** Co expects headwind of $40 mln in 2026, $70 mln in 2027 with the expiration of the Affordable Care Act subsidy, but will be offset by elimination of $45 mln cyber-incident impact in 2025, says chief financial officer Joel Ackerman

** Co reports Q4 adj. EPS of $3.4 vs analysts' estimate of $3.16 - LSEG data

** Q4 profit lifted by higher reimbursement rates and a slight improvement in the mix and seasonal impact of flu vaccines, says co

** DVA stock dropped 24% in 2025

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.